Q2 2026 13F · SEC CIK 1846444
Sands Capital Alternatives, LLC
Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $613.5M
- Reported positions
- 24
- Top holdings a year, 3 yrs
- +9.8%
- Assets under management
- $5.4B
Sands Capital Alternatives, LLC is a hedge fund that reported 24 positions worth $613.5M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Alamar Biosciences Inc (ALMR, 18.7%), Nu Hldgs Ltd (NU, 15.4%), Klaviyo Inc (KVYO, 9.7%). A portfolio copying its top holdings returned 9.8% a year over the last 3 years, against 20.4% for the S&P 500.
Sands Capital Alternatives, LLC holdings all 24 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| ALMRAlamar Biosciences Inc | 18.7% | — | $114.6M |
| NUNu Hldgs Ltd | 15.4% | +8.5% | $94.8M |
| KVYOKlaviyo Inc | 9.7% | +7.6% | $59.3M |
| BBNXBeta Bionics Inc | 9.5% | +0.0% | $58.1M |
| SGPSpyglass Pharma Inc | 9.1% | +0.0% | $55.7M |
| IKTInhibikase Therapeutics Inc | 4.3% | +0.0% | $26.4M |
| DASHDoordash Inc | 3.8% | +14.7% | $23.5M |
| CPNGCoupang Inc | 3.8% | +31.3% | $23.1M |
| DDOGDatadog Inc | 3.4% | -5.8% | $21.1M |
| BIOABioage Labs Inc | 3.1% | +0.0% | $19.3M |
| TXG10x Genomics Inc | 3.0% | +0.0% | $18.5M |
| IOTSamsara, Inc. | 2.7% | -8.0% | $16.7M |
| ODTXOdyssey Therapeutics, Inc. | 2.7% | — | $16.4M |
| TOSTToast Inc | 1.7% | +21.0% | $10.2M |
| ABOSAcumen Pharmaceuticals Inc | 1.6% | +0.0% | $9.9M |
| TTANServiceTitan, Inc. | 1.3% | +20.8% | $7.7M |
| CBRSCerebras Systems Inc | 1.2% | — | $7.3M |
| SNOWSnowflake Inc | 1.0% | +21.0% | $6.2M |
| MNDYMonday Com Ltd | 1.0% | +20.8% | $5.9M |
| TARSTarsus Pharmaceuticals Inc | 0.9% | +0.0% | $5.3M |
| TSHATaysha Gene Therapies Inc | 0.8% | +0.0% | $4.9M |
| CADLCandel Therapeutics Inc | 0.7% | +0.0% | $4.2M |
| ACRVAcrivon Therapeutics Inc | 0.7% | +7.9% | $4.1M |
| FIGFigma Inc | 0.1% | +21.2% | $401K |
What Sands Capital Alternatives, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- ALMR Alamar Biosciences Inc18.7% of 13F
- ODTX Odyssey Therapeutics, Inc.2.7% of 13F
- CBRS Cerebras Systems Inc1.2% of 13F
Added to
- CPNG Coupang Inc+31.3% shares
- FIG Figma Inc+21.2% shares
- TOST Toast Inc+21.0% shares
- SNOW Snowflake Inc+21.0% shares
- TTAN ServiceTitan, Inc.+20.8% shares
- MNDY Monday Com Ltd+20.8% shares
- DASH Doordash Inc+14.7% shares
- NU Nu Hldgs Ltd+8.5% shares
Reduced
- IOT Samsara, Inc.-8.0% shares
- DDOG Datadog Inc-5.8% shares
Sold out
Nothing sold out.
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- -9.2% /yr
- S&P 500 +20.1%
- 3 years
- +9.8% /yr
- S&P 500 +20.4%
- 5 years
- -5.3% /yr
- S&P 500 +11.2%
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $613.5M | 24 |
| Q1 2026 | $421.2M | 21 |
| Q4 2025 | $518.5M | 20 |
| Q3 2025 | $456.4M | 20 |
| Q2 2025 | $507.8M | 19 |
| Q1 2025 | $408.9M | 20 |
| Q4 2024 | $459.7M | 21 |
| Q3 2024 | $355.8M | 20 |
| Q2 2024 | $298.6M | 20 |
| Q1 2024 | $414.7M | 20 |
| Q4 2023 | $359.5M | 21 |
| Q3 2023 | $338.0M | 23 |
Questions about Sands Capital Alternatives, LLC's portfolio
What stocks does Sands Capital Alternatives, LLC own?
Sands Capital Alternatives, LLC's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 24 positions worth $613.5M. The largest are Alamar Biosciences Inc (ALMR) at 18.7%, Nu Hldgs Ltd (NU) at 15.4%, Klaviyo Inc (KVYO) at 9.7%, Beta Bionics Inc (BBNX) at 9.5% and Spyglass Pharma Inc (SGP) at 9.1%.
What did Sands Capital Alternatives, LLC buy last quarter?
In Q2 2026, Sands Capital Alternatives, LLC added a new position in Alamar Biosciences Inc (ALMR), a new position in Odyssey Therapeutics, Inc. (ODTX), a new position in Cerebras Systems Inc (CBRS), Coupang Inc (CPNG) (+31.3% shares), Figma Inc (FIG) (+21.2% shares) and Toast Inc (TOST) (+21.0% shares), compared with its Q1 2026 filing.
What did Sands Capital Alternatives, LLC sell last quarter?
In Q2 2026, Sands Capital Alternatives, LLC Samsara, Inc. (IOT) (-8.0% shares) and Datadog Inc (DDOG) (-5.8% shares), compared with its Q1 2026 filing.
How has Sands Capital Alternatives, LLC's portfolio performed?
A portfolio copying Sands Capital Alternatives, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +9.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: -9.2% against +20.1%. Over 5 years: -5.3% a year against +11.2%.
When is Sands Capital Alternatives, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Sands Capital Alternatives, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Sands Capital Alternatives, LLC manage?
Sands Capital Alternatives, LLC reported $5.4B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $613.5M.